Celebrating ESWI 30 years!

Dr. Hannoun’s education includes a Ph.D. in Microbiology, which he earned in Paris, France.

Dr. Hannoun is an expert at the WHO (viral diseases). His former positions include: Director of the National Influenza Reference Centre, Professor at the Pasteur Institute, Associate Professor at the Université of Paris VII, Scientific Director of GROG systems (Groupes Régionaux d’Observation de la Grippe), Director of the WHO Collaborating Centre for influenza and other respiratory viruses, Honorary Professor at the Pasteur Institute and Vice-President of ‘Société Française de Microbiologie’. He was Co-Founder and Chairman of ESWI from 1992 until 1998. He was Co-Organiser of the Conference ‘Options for the control of influenza II’ Courchevel in December 1992, the Conference “Options for the Control of Influenza IV” in Crete in 2000 and of the “First European Influenza Conference” (ESWI) in Malta in 2002. He was also Editor-in-Chief of the ‘European Journal f Epidemiology’.

Dr. Hannoun’s scientific activities are mainly oriented towards virological and epidemiological studies on arboviruses and influenza. The activity of several arboviruses so far unknown in France has been demonstrated as having occurred between 1960 and 1975, the most important being the West Nile virus. During the following years, national and international development of surveillance networks (GROG) for early detection of influenza epidemics and applications in the field of control of influenza (vaccines and antivirals) and other respiratory viral infections have been major subjects of interest, together with research programmes on virus structures. He pays special attention to infections caused by influenza virus type C and on the characteristics of this little known virus. Further studies in the field of influenza include evaluation of immunisation adjuvants, antiviral screening and tissue culture vaccines in addition to the epidemiological surveillance of respiratory viral infections.

Position: Director of the Center of Infection Medicine and Zoonosis Research and Guest-Professor at the University of Veterinary Medicine Hannover.



Research fields: Emerging virus infections of humans and animals



Professor Osterhaus is Director of the Center of Infection Medicine and Zoonosis Research at the University of Veterinary Medicine Hannover, Germany, and cofounder/CSO of Viroclinics-DDL BV and ViroNative BV (both spin-outs of Erasmus MC) and CR2O. He was head of the Department of Viroscience at Erasmus MC Rotterdam until 2014.



He has a long track record as a researcher and project leader of numerous major scientific projects. At Erasmus MC, he has run a diagnostic virology lab with more than 40 staff and a research virology lab with over 150 personnel. His research programme follows an integrated “viroscience” concept, bringing together world-leading scientists in molecular virology, immunology, epidemiology, pathogenesis, and intervention studies for human and animal virus infections.



Among his major accomplishments are the discovery of more than 70 new viruses of humans and animals (e.g. human metapneumovirus, coronaviruses, influenza viruses), elucidation of the pathogenesis of major human and animal virus infections, and development of novel intervention strategies. This has enabled health authorities like the WHO to effectively combat disease outbreaks like SARS and avian influenza. The established spin-outs are among his other societally relevant successes, allowing effective testing and refining of diagnostic tools and other intervention strategies.



Professor Osterhaus has acted as mentor for more than 80 PhD students and holds several key patents. He is the author of more than 1300 papers in peer-reviewed journals, together cited more than 75,000 times with an H index of 120. He holds several senior editorships and has received numerous prestigious awards. He is a member of the Dutch and German National Academies of Sciences, member of the Belgium Academia of Medicine, and Commander of the Order of the Dutch Lion.

Nationality: American, British



Position: Professor of Applied Evolutionary Biology, University of Amsterdam Faculty of Medicine



Research field: Virus Evolution



ESWI member since 2019



Professor Russell was a member of the University of Cambridge from 2002 to 2017; first as a PhD student, then postdoctoral research associate (2006) and junior research fellow (2008), and finally as a Royal Society University Research Fellow (2009). From 2008 to 2011, he was also a research fellow at the US National Institutes of Health. In 2017, he moved to AMC (Academic Medical Center, university hospital and Faculty of Medicine of the University of Amsterdam) to head the Laboratory of Applied Evolutionary Biology.



Prof Russell’s research focuses on connecting processes at the within-host, between-host, and population scales, to understand the dynamics of influenza viruses and other respiratory pathogens. His research uses a combination of wet-lab and computational tools to study the interactions of processes at each of these scales. In addition to his research activities, he has been an advisor to the WHO influenza vaccine strain selection committee and he is the chair of the Infection Program of the Amsterdam Institute of Infection and Immunity.



Prof Russell has published extensively in leading scientific journals including Science, Nature, PNAS, and eLife. He is also the recipient of substantial research funding including grants from the Royal Society (UK), the US National Institutes of Health, and the Wellcome Trust. He is a current ERC and NWO Vici laureate.